Silke Radetzki

Statistics

Publications

Citations

H-Index

Active since

2001

Affiliations

Leibniz-Forschungsinstitut für Molekulare Pharmakologie(Current)

Charité - Universitätsmedizin Berlin

Max Delbrück Center

Humboldt-Universität zu Berlin

Freie Universität Berlin

Silke Radetzki is an author at Leibniz-Forschungsinstitut für Molekulare Pharmakologie specializing in oncology, molecular oncology, and pharmacology.

ORCID

Publications per year

2001–2024

Publications

Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance

Katrin Friedrich, Thomas Wieder, Clarissa von Haefen et al. · Oncogene · 2001 · 121 citations

Life Sciences, Cell Biology, Oncology +15

Analysis of p53/BAX/p16<sup>ink4a/CDKN2</sup> in Esophageal Squamous Cell Carcinoma: High BAX and p16<sup>ink4a/CDKN2</sup> Identifies Patients With Good Prognosis

Isrid Sturm, Henrik Petrowsky, Roland Volz et al. · Journal of Clinical Oncology · 2001 · 109 citations

Medicine, Oncology, Pathology +17

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma

Isrid Sturm, Carsten Stephan, Bernhard Gillissen et al. · Cell Death and Differentiation · 2005 · 106 citations

Medicine, Cell Biology, Oncology +12

Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1

Manisha Juneja, Dennis Kobelt, Wolfgang Walther et al. · PLoS Biology · 2017 · 86 citations · Full text

Medicine, Oncology, Pharmacology +14

Selective Inhibitors of the Protein Tyrosine Phosphatase SHP2 Block Cellular Motility and Growth of Cancer Cells in vitro and in vivo

Stefanie Grosskopf, Chris Eckert, Christoph Arkona et al. · ChemMedChem · 2015 · 82 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 22